Gold Medal. st Annual Albert B. Sabin. Award Ceremony. Mathuram Santosham, M.D., M.P.H.

Similar documents
Gold Medal. nd Annual Albert B. Sabin. Award Ceremony. Roger I. Glass, M.D., Ph.D. Presented to

th Annual Albert B. Sabin Gold Medal Award Ceremony

Gold Medal. Paul A. Offit, M.D. th Annual Albert B. Sabin. Ceremony. Presented to

Randomized Controlled Vaccine Trials

2012 Gold Medal Award Ceremony Remarks

ANNUAL REPORT. Improving lives through immunization

2006 Albert B. Sabin Gold Medal

With your help, our goal is to protect millions more against serious illness through the development of new vaccines and other preventions.

Creating VaCCines, ProteCting Life

All About Vaccines and How They Get to Those Who Need Them Most. Elesha Kingshott

SPONSORSHIP OPPORTUNITIES JUNE 12-13, umanitoba.ca/cgph

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

Childhood Vaccination and Immunisation

In the Name of God, the Compassionate, the Merciful. Address by DR HUSSEIN A. GEZAIRY REGIONAL DIRECTOR WHO EASTERN MEDITERRANEAN REGION.

VACCINE FACT BOOK 2012

Common Virus and Senseless Killer: A Briefing Paper on Rotavirus

SPONSORSHIP OPPORTUNITIES JUNE 12-13, umanitoba.ca/cgph

New vaccine technologies: Promising advances may save more lives

VACCINE MARKETS OVERVIEW SESSION

JANUARY One Shot, One Life Saved. Measles Initiative Saves a Child for $1

A Briefing Paper on Rotavirus

innovative finance The GAVI Matching Fund A public-private partnership to save children s lives

History of Vaccines. Stanley A. Plotkin ADVAC HISTORY /21/ :21 AM

The power of innovation to save lives

2. Provide an opportunity for networking with other professionals who share an interest in improving care for older adults.

Call for Nominations. Opens: May 1, 2017 Deadline: September 30, 2017

Roger I. Glass, M.D., Ph.D. Fogarty International Center, NIH Viral Gastroenteritis Unit, CDC

Overview. Vaccine innovation With people, for people: The (A) citizens' view. Vaccine impact in perspective. Vaccine research in perspective

Fact sheet. Poliomyelitis. WHO Media centre. ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM

FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated ) USAID Global Health Programs (GHP) and State Department

innovative finance The GAVI Matching Fund A public-private partnership to save children s lives

Impact of American Indian Research on Global Health

GAVI Role in IPV Introductions

Hep B United National Summit Report July 27-29, 2016 Washington, D.C.

Childhood Pneumonia & Meningitis: Recent Advances

Vaccines, Autism, and Blue Marble Health

LEADING DENGUE VACCINE CANDIDATE COULD CHANGE THE LIVES OF MILLIONS

TOLUCA, ESTADO DE MEXICO, MEXICO. OCTOBER

A better way to speed the adoption of vaccines

Access to vaccination in GAVI countries and at global level

Nobel Laureate Harold Varmus Joins Weill Cornell Medical College to Advance Cancer Research

Media Coverage World Health Organisation Grants Prequalification to Bharat Biotech s rotavirus vaccine, ROTAVAC(R)

Vaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines

In Case of Technical Difficulties

RELAY FOR LIFE AT LATROBE MEMORIAL STADIUM 2009

JAY A. NELSON, PH.D. Executive Director and Vice President

High Cost Is the Primary Barrier Reported by Physicians Who Prescribe Vaccines Not Included in India s Universal Immunization Program

Vaccination: lost opportunities

D.A.Henderson, MD, MPH. Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine

MVP as an example of a project managed approach to develop a needed vaccine

Padma Shri Professor Mahdi Hasan Award -for clinical research - Recipient (2014) : Prof. Lalit Kumar

Vaccine Introduction & Uptake Timing Benchmark Project

Vaccinology Overview. Complexity of the Vaccine Approval Process Including Lessons Learned

Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines

VACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine

DEPARTMENT OF INTERNATIONAL HEALTH

Alzheimer s & Caregiving: An Evening with Kim Campbell

KURUKSHETRA JULY 2017 RURAL HEALTH

Perspectives on Ensuring Access to Vaccines in Lower Income Countries

Ministry of health. Our Community

BA Washington University, Biology and Anthropology May 2006 Graduated Cum Laude

Global health and vaccination: TB & beyond. Dr Mary Moran Executive Director

PNEUMONIA REPORT CARD TUESDAY, NOVEMBER 9, 2010 EMBARGOED UNTIL NOVEMBER 12, 2010

With United Way your business goals and community goals align.

PRINCIPLES OF VACCINE PORTFOLIO PRIORITIZATION AND MANAGEMENT

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector

Hilleman Laboratories

NFID Vision. Healthier lives through effective prevention, diagnosis, and treatment of infectious diseases

Diarrhea is well known to be a leading cause of. Oral Rehydration Therapy for Diarrhea: An Example of Reverse Transfer of Technology

Thank you for the opportunity to submit testimony on the Fiscal Year (FY) 2014 State

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

Gourmet Gala SPONSORSHIP PROPOSAL. May 8 th, National Building Museum WHEN WHERE

Strengthening evidence-based decision making for new vaccine introduction: PAHO s ProVac Initiative

VIEW-hub Report: Global Vaccine Introduction and Implementation

Laureates of the Second Hideyo Noguchi Africa Prize

SUNDAY, MARCH 24 TUESDAY, MARCH 26, 2019 THE MAYFLOWER HOTEL, WASHINGTON, DC 20 Y E A R S CELEBRATING 20 YEARS OF QUALITY

MEMBERSHIP. Early-Career Professional. Specialized support for a successful transition from student to professional

SPONSORSHIP OPPORTUNITIES. October 27, 2016 National Constitution Center. Supporting the:

Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,

Gavi s private sector engagement approach

Fast-Forwarding a Cure for Melanoma

VISION. for a world free from infectious and neglected diseases

Be One of the 50+ Speakers at the Three Parallel Sessions! Abstracts Submission Deadline November 30 1 h, 2017

Diabetes, Nutrition, Metabolism & Medicare

Global Congress 2012

Finding Adequate Reward in Life: Dopamine and the Brain

Challenges to Sustaining National Immunization Programs in Developing Countries

Global Health Policy: Vaccines

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer

Vaccine preventable diseases

SPONSORSHIP OPPORTUNITIES

Developing the next generation of infection and immunity leaders. The Peter Doherty Institute for Infection and Immunity

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

SPONSORSHIP OPPORTUNITIES

American Psychdqgical Association

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036

HOOKVAC EU-US-Africa collaboration towards a vaccine for hookworm

MODULE SIX. Global TB Institutions and Policy Framework. Treatment Action Group TB/HIV Advocacy Toolkit

PAEDIATRIC ASSOCIATION OF NIGERIA & CONTRIBUTIONS TO IMMUNIZATIONS IN NIGERIA

Transcription:

21 st Annual Albert B. Sabin Gold Medal Award Ceremony Presented to Mathuram Santosham,, M.P.H. for his outstanding research and public health efforts to prevent H. influenzae type b (Hib) diseases Tuesday, April 29, 2014 Bethesda North Marriott Hotel & Conference Center North Bethesda, MD

Ceremony Program 5:30 PM REGISTRATION & REFRESHMENTS 6:30 PM WELCOME Peter J. Hotez,, Ph.D. President, Sabin Vaccine Institute; Director, Sabin Vaccine Institute and Texas Children s Hospital Center for Vaccine Development; Dean, National School of Tropical Medicine at Baylor College of Medicine 7:30 PM COFFEE & DESSERT INTRODUCTION & PRESENTATION OF THE ALBERT B. SABIN GOLD MEDAL Katherine L. O Brien,, M.P.H. Professor, Johns Hopkins Bloomberg School of Public Health ACCEPTANCE Mathuram Santosham,, M.P.H. Professor of Pediatrics and International Health Director, Center for American Indian Health Johns Hopkins University

About Sabin Vaccine Institute The Sabin Vaccine Institute (Sabin) is a non-profit, 501(c)(3) organization of scientists, researchers and advocates dedicated to reducing needless human suffering from vaccine-preventable and neglected tropical diseases (NTDs). Since its founding in 1993 in honor of Dr. Albert B. Sabin, the developer of the oral polio vaccine, Sabin has been at the forefront of global efforts to eliminate, prevent, and cure infectious and neglected tropical diseases. Sabin develops new vaccines, advocates for increased use of existing vaccines and promotes expanded access to affordable medical treatments in collaboration with governments, academic institutions, scientists, medical professionals and other non-profit organizations.

About Dr. Albert B. Sabin After receiving his medical degree in 1931, Dr. Sabin began research on poliomyelitis (polio), which at the time had reached epidemic proportions around the globe. At the Children s Hospital Research Foundation in Cincinnati, Ohio, he was able to prove that polio was an infection of the alimentary tract, indicating that polio might be prevented by an oral vaccine. Dr. Sabin s early research was interrupted by World War II. He joined the U.S. Army Dr. Sabin administers his oral vaccine to two Cincinnati children - 1960s Epidemiological Board s Virus Committee in 1941 and accepted assignments abroad, where he worked on vaccines for encephalitis, visceral leishmaniasis and dengue fever. At the end of World War II, Dr. Sabin returned to Cincinnati and resumed his research. He focused on isolating a mutant form of the polio virus incapable of producing the disease and thereby safe for introduction to the human body. The avirulent virus reproduced rapidly in the intestines, displacing lethal forms of the polio virus and providing protection from the disease. The oral vaccine was first tested outside the United States from 1957 to 1959 and introduced in the American public in 1959.

Since then, the Sabin vaccine has been used to eliminate polio in countries throughout the world. Dr. Sabin dedicated his entire professional career to the elimination of human suffering though his groundbreaking medical advances, while also waging a lifelong campaign against poverty and the resulting health inequities. It was in this spirit of commitment and dedication that his longtime friends and colleagues - led by Heloisa Sabin, his widow, and the late Dr. H.R. Shepherd, Sabin s Founding Chairman - established the Sabin Vaccine Institute in 1993 following Dr. Sabin s death. Dr. Sabin in his laboratory - 1955 Dr. Sabin - 1980s Images of Dr. Sabin courtesy of Winkler Center for the Health Professions, University of Cincinnati

About Mathuram Santosham,, M.P.H Dr. Mathuram Santosham was born in Vellore, India and obtained his M.B.B.S. degree from the Jawaharlal Institute of Post Graduate Medical Education and Research (JIPMER) in Pondicherry, India in 1970. He subsequently moved to the U.S. and obtained Board Certification in Pediatrics and an M.P.H. degree from the Johns Hopkins University. He also completed a Fellowship in Pediatric Infectious Diseases at Johns Hopkins Hospital. Dr. Santosham is the Founder and Director of the Johns Hopkins Center for American Indian Health. He holds Professorships in the Department of International Health and the Department of Pediatrics at Johns Hopkins University. He directed the Division of Health Systems for the Johns Hopkins Bloomberg School of Public Health from 1999-2009. Dr. Santosham is internationally known for his work on oral rehydration therapy, childhood vaccines and dissemination of key

child survival interventions to vulnerable populations worldwide. Dr. Santosham worked with the White Mountain Apache Tribe and in several developing countries to pioneer the use of oral rehydration solution (ORS), now known as Pedialyte in the U.S. Based on this and other evidence, ORS has become the standard of care for treating diarrheal dehydration, and is credited with saving an estimated 60 million lives since 1980. Working in partnership with Native American communities, he conducted landmark vaccine efficacy trials, including rotavirus vaccine, H. influenzae type b (Hib) conjugate vaccine and pneumococcal conjugate vaccine trials. Native American children used to die from these diseases at rates 5 to 10 times the U.S. average. Thanks largely to his advocacy, these vaccines now save 3 to 5 million lives a year in the U.S. and across the globe. Dr. Santosham was the lead for a project called the Hib Initiative, funded by GAVI. The Hib Initiative consortium consisted of representatives of Johns Hopkins University, London School of Tropical Medicine and Hygiene, Centers for Disease Control (CDC) and World Health Organization (WHO). When the Hib Initiative began in 2005, only 20% of the GAVI-eligible (poorest) countries were using the Hib vaccine. Now, every GAVI-eligible country in the world is either using the vaccine or has made the decision to introduce it. GAVI estimates that by 2020, Hib vaccines will have prevented over 7 million deaths. Dr. Santosham drawing blood from an Apache infant - mid 1980s Dr. Santosham serves on numerous national and international committees to promote childhood health throughout the world. He consults for numerous international agencies including WHO, U.S. Agency for International Development, UNICEF and the Bill &

Melinda Gates Foundation on aspects of child survival in over 30 countries. He is the author of over 250 peer-reviewed journals and serves as a reviewer for several international medical journals. He is the recipient of numerous awards including the Thrasher Research Fund Dr. Santosham holding an Apache child during a community celebration - early 1990s Award for Excellence in Research (1988), the Robert Austrian Orator for the International Symposium on Pneumococci and Pneumococcal Diseases (2006) and the Maurice Hilleman Lecturer at CDC (2008). He was also awarded the Indian Health Service Directors Award for Career Service in 2011, recognizing his personal dedication, commitment and contribution to American Indian and Alaska Native health and the global impact of his research and advocacy. Dr. Santosham & Dr. O Brien - 2008

About the Albert B. Sabin Gold Medal Award Awarded annually since 1994, the Albert B. Sabin Gold Medal Award recognizes a researcher who has made extraordinary contributions in the field of vaccinology or a complementary field. This year marks the 21st year that Sabin has bestowed the award. We applaud all of our past winners on their contributions to improving health worldwide. Albert B. Sabin Gold Medal Award Recipients (2014-1994) 2014 Mathuram Santosham,, M.P.H. 2013 Anne A. Gershon, 2012 F. Marc LaForce, 2011 Douglas R. Lowy,

2011 John T. Schiller, Ph.D. 2010 John D. Clemens, 2009 Rino Rappuoli, Ph.D. 2008 Ruth S. Nussenzweig,, Ph.D. 2007 Hilary Koprowski, (d. 2013) 2006 William H. Foege,, M.P.H. 2005 Albert Z. Kapikian, (d. 2014) 2004 William S. Jordan, Jr., (d. 2008) 2003 Samuel L. Katz,, D.Sc. 2002 Stanley A. Plotkin, 2001 John B. Robbins, 2000 Ciro A. de Quadros,, M.P.H.

1999 Maj. Gen. Philip K. Russell, (USA Ret.) 1998 Allen C. Steere, 1998 Myron M. Levine,, D.T.P.H. 1997 Maurice R. Hilleman, Ph.D., D.Sc. (d. 2005) 1996 Joseph L. Melnick, Ph.D. (d. 2001) 1995 Robert M. Chanock, (d. 2010) 1994 Donald A. Henderson,, M.P.H.

The Sabin Vaccine Institute gratefully acknowledges those who helped make the 2014 Albert B. Sabin Gold Medal Award Ceremony possible. PRESENTING SPONSOR UNDERWRITER LEADERS SUPPORTER 2000 Pennsylvania Avenue, NW Suite 7100 Washington, DC 20006 www.sabin.org